Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells

Journal of Neuroscience Research

Volumn 79, Issue 4, 2005, Pages 495-502

  Carreras, Isabel ^a   Garrett Young, Rosemary ^a   Ullman, M David ^a,c   Eisenhauer, Patricia B ^a,b   Fine, Richard E ^a,b   Wells, John M ^a,b   Conn, Kelly J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Gene expression; Parkinson's disease; Proteasome

Indexed keywords

CLUSTERIN; GLYCOPROTEIN; HEAT SHOCK PROTEIN; ISOPROTEIN; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN;

ARTICLE; BRAIN DEGENERATION; CELL DEATH; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; HUMAN CELL; LEWY BODY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CLUSTERIN; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; MOLECULAR CHAPERONES; NEUROBLASTOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TIME FACTORS; UP-REGULATION;

EID: 14144250189     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20374     Document Type: Article

References (62)

1. Ahuja HS, Tenniswood M, Lockshin R, Zakeri ZF. 1994. Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 72:523-530.
2. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. 1998. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516-520.
3. Andersen JK. 2000. What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease? Mech Ageing Dev 118:15-22.
4. Bailey RW, Dunker AK, Brown CJ, Garner EC, Griswold MD. 2001. Clusterin, a binding protein with a molten globule-like region. Biochemistry 40:11828-11840.
5. Bursch W, Gleeson T, Kleine L, Tenniswood M. 1995. Expression of clusterin (testosterone-repressed prostate message-2) mRNA during growth and regeneration of rat liver. Arch Toxicol 69:253-258.
6. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS. 1989. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9:3473-3481.
7. Caccamo AE, Scaltriti M, Caporali A, D'Arca D, Scorcioni F, Candiano G, Mangiola M, Bettuzzi S. 2003. Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann N Y Acad Sci 1010:514-519.
8. Caccamo AE, Scaltriti M, Caporali A, D'Arca D, Scorcioni F, Astancolle S, Mangiola M, Bettuzzi S. 2004. Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of 45 kDa nuclear isoform of clusterin. Biochem J 382:157-168.
9. Carrell RW, Lomas DA. 1997. Conformational disease. Lancet 350:134-138.
10. Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, Tobe T, Tomita M. 1992. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol (Berl) 83:260-264.
11. Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES. 2003. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 278:28026-28037.
12. Chung KK, Dawson VL, Dawson TM. 2001. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 24(Suppl):7-14.
13. Clark AM, Griswold MD. 1997. Expression of clusterin/sulfated glycoprotein-2 under conditions of heat stress in rat Sertoli cells and a mouse Sertoli cell line. J Androl 18:257-263.
14. Conn KJ, Gao WW, Ullman MD, McKeon-O'Malley C, Eisenhauer PB, Fine RE, Wells JM. 2001. Specific upregulation of GADD153/CHOP in MPP+-treated SH-SY5Y cells. J Neurosci Res 68:755-760.
15. Conn KJ, Ullman MD, Larned MJ, Eisenhauer PB, Fine RE, Wells JM. 2003. cDNA microarray analysis of changes in gene expression associated with MPP+ toxicity in SH-SY5Y Cells. Neurochem Res 28:1873-1881.
16. Criswell T, Klokov D, Beman M, Lavik JP, Boothman DA. 2003. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol Ther 2:372-380.
17. Danik M, Chabot JG, Mercier C, Benabid AL, Chauvin C, Quirion R, Suh M. 1991. Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc Natl Acad Sci USA 88:8577-8581.
18. Dauer W, Przedborski S. 2003. Parkinson's disease: mechanisms and models. Neuron 39:889-909.
19. Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822.
20. Debure L, Vayssiere JL, Rincheval V, Loison F, Le DY, Michel D. 2003. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J Cell Sci 116:3109-3121.
21. DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM. 2002. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 99:10843-10848.
22. Dickson DW. 2001. Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 14:423-432.
23. Fenteany G, Schreiber SL. 1998. Lactacystin, proteasome function, and cell fate. J Biol Chem 273:8545-8548.
24. Forno LS. 1996. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272.
25. Halliwell B. 2002. Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann N Y Acad Sci 962:182-194.
26. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425-479.
27. Hochstrasser M. 1996. Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405-439.
28. Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. 1999. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274:6875-6881.
29. Jones SE, Jomary C. 2002. Clusterin. Int J Biochem Cell Biol 34:427-431.
30. Kaufman RJ. 1999. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13:1211-1233.
31. Kimura K, Asami K, Yamamoto M. 1997. Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells. Cell Biochem Funct 15:251-257.
32. Lakins J, Bennett SA, Chen JH, Arnold JM, Morrissey C, Wong P, O'Sullivan J, Tenniswood M. 1998. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J Biol Chem 273:27887-27895.
33. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. 2003. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278:11590-11600.
34. Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K. 1998. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 154:511-521.
35. May PC. 1993. Sulfated glycoprotein-2: an emerging molecular marker for neurodegeneration. Ann N Y Acad Sci 679:235-244.
36. May PC, Finch CE. 1992. Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci 15:391-396.
37. McGeer PL, Kawamata T, Walker DG. 1992. Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337-341.
38. McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P. 2001. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci 2:589-594.
39. McNaught KS, Perl DP, Brownell AL, Olanow CW. 2004. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 56:149-162.
40. McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW. 2002. Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136-2148.
41. Michel D, Chatelain G, North S, Brun G. 1997. Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328:45-50.
42. Morgan TE, Laping NJ, Rozovsky I, Oda T, Hogan TH, Finch CE, Pasinetti GM. 1995. Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions. J Neuroimmunol 58:101-110.
43. Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson SA, Finch CE. 1994. Purification and characterization of brain clusterin. Biochem Biophys Res Commun 204:1131-1136.
44. Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE. 1994. Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 339:387-400.
45. Poon S, Treweek TM, Wilson MR, Easterbrook-Smith SB, Carver JA. 2002. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett 513:259-266.
46. Popper P, Farber DB, Micevych PE, Minoofar K, Bronstein JM. 1997. TRPM-2 expression and TUNEL staining in neurodegenerative diseases: studies in wobbler and rd mice. Exp Neurol 143:246-254.
47. Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE. 2001. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 276:33869-33874.
48. Reddy KB, Karode MC, Harmony AK, Howe PH. 1996. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin. Biochemistry 35:309-314.
49. Rosenberg ME, Silkensen J. 1995. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27:633-645.
50. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386.
51. Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T. 2002. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Acta Neuropathol (Berl) 104:225-230.
52. Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C. 1995. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 55:2431-2437.
53. Senut MC, Jazat F, Choi NH, Lamour Y. 1992. Protein SP40,40-like immunoreactivity in the rat brain: progressive increase with age. Eur J Neurosci 4:917-928.
54. Sherman MY, Goldberg AL. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15-32.
55. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. 1992. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 11:197-220.
56. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del TD, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
57. Voges D, Zwickl P, Baumeister W. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015-1068.
58. Wilson MR, Easterbrook-Smith SB. 2000. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25:95-98.
59. Wong P. 1994. Apoptosis, retinitis pigmentosa, and degeneration. Biochem Cell Biol 72:489-498.
60. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. 2000. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 97:5907-5912.
61. Yang CR, Yeh S, Leskov K, Odegaard E, Hsu HL, Chang C, Kinsella TJ, Chen DJ, Boothman DA. 1999. Isolation of Ku70-binding proteins (KUBs). Nucleic Acids Res 27:2165-2174.
62. Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J. 2004. Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279:39155-39164.